Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Proportionality of GLA5PR GLARS-NF1 in Healthy Volunteers
NCT02327000Phase 1Completed
- Sponsor
- GL Pharm Tech Corp
- Start
- Oct 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of pregabalin in neuropathic pain (4 arms), sponsored by GL Pharm Tech Corp. Primary endpoints: Area Under the Curve to the Last Measurable Concentration and Maximum Plasma Concentration. Started Oct 2014; status: completed.
02
Drugs
pregabalin
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT02327000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02327000.